CBD Life Sciences Inc. (OTC:CBDL) Stock Soars On Expanding Revenue Stream: What To Do Now?

If you are currently looking into stocks that made strong gains on Tuesday, then you could do well to take a closer look into CBD Life Sciences Inc. (OTC:CBDL). The company’s stock made a strong upward move yesterday and clocked gains of 33% for the day.

CBD Life Sciences, Inc. (CBDL) Announces Expanding Revenue Stream With Walmart Marketplace

The company, a leader in the innovative CBD products space, announced yesterday that its line of flagship products had been launched on the Walmart Marketplace.

In the news release, the company noted that the development was a major milestone in CBD Life Sciences’ retail strategy. The launch would help the company in bringing about considerable growth in revenues and expand the reach of its products to potentially millions of new customers.

The Walmart Marketplace is one of the world’s biggest retail platforms, and hence, CBD Life Sciences’ products would be immediately accessible to as many as 120 million monthly visitors. It would help the company in not only strengthening its brand visibility but also its consumer base.

Due to the addition of the new distribution channel, the company projected growth of 35% in annual sales. In the past 12 months, the company’s revenues have already grown by 20%. It remains to be seen if the CBD Life Sciences stock records further gains today.

CEO Statement

“Our launch on Walmart Marketplace represents a monumental step forward in our growth strategy,” said Lisa Nelson, CEO of CBD Life Sciences, Inc. “We are not only expanding our reach but enhancing our capacity to deliver value to our investors. The CBD market is poised for explosive growth, and with this new distribution channel, we are strategically positioned to capitalize on the rising consumer demand.”

Ian Leigh

Ian Leigh is a specialist in analyzing stocks, SEC and OTC filings, and financials of public and privately-held companies. He has played a significant role in M&A activity, consulting with publicly-held firms on acquisitions and divestitures. He also consults on valuations and branding. He lectures at major universities and teaches at specialty financial schools.